Literature DB >> 26828437

Intrinsic GTP hydrolysis is observed for a switch 1 variant of Cdc42 in the presence of a specific GTPase inhibitor.

Kyla M Morris1, Rory Henderson1, Thallapuranam Krishnaswamy Suresh Kumar1, Colin D Heyes1, Paul D Adams1.   

Abstract

The Ras-related protein Cell division cycle 42 (Cdc42) is important in cell-signaling processes. Protein interactions involving Cdc42 occur primarily in flexible "Switch" regions that help regulate effector binding. We studied the kinetics of intrinsic GTP hydrolysis reaction in the absence and presence of a biologically active peptide derivative of a p21-activated kinase effector (PBD46) for wt Cdc42 and compared it to the Switch 1 variant Cdc42(T35A). While the binding of PBD46 to wt Cdc42 results in complete inhibition of GTP hydrolysis, this interaction in Cdc42(T35A) does not. Comparison of the crystal structure of wt Cdc42 in the absence of effector (1AN0.pdb), as well as the NMR structure of wt Cdc42 bound to an effector in the Switch 1 region (1CF4.pdb) ( www.rcsb.org ) suggests that the orientation of T(35) with bound Mg(2+) changes in the presence of effector, resulting in movement of GTP away from the catalytic box leading to the inhibition of GTP hydrolysis. For Cdc42(T35A), molecular dynamics simulations and structural analyses suggest that the nucleotide does not undergo the conformational shift observed for the wt Cdc42-effector interaction. Our data suggest that change in dynamics in the Switch 1 region of Cdc42 caused by the T35A mutation (Chandrashekar, et al. 2011, Biochemistry, 50, p. 6196) fosters a conformation for this Cdc42 variant that allows hydrolysis of GTP in the presence of PBD46, and that alteration of the conformational dynamics could potentially modulate Ras-related over-activity.

Entities:  

Keywords:  GTP hydrolysis; cell division cycle 42 (Cdc42); protein dynamics; ras; switch 1 variant

Mesh:

Substances:

Year:  2016        PMID: 26828437      PMCID: PMC4905262          DOI: 10.1080/21541248.2015.1123797

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  35 in total

1.  Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK.

Authors:  H R Mott; D Owen; D Nietlispach; P N Lowe; E Manser; L Lim; E D Laue
Journal:  Nature       Date:  1999-05-27       Impact factor: 49.962

2.  Structure of Cdc42 bound to the GTPase binding domain of PAK.

Authors:  A Morreale; M Venkatesan; H R Mott; D Owen; D Nietlispach; P N Lowe; E D Laue
Journal:  Nat Struct Biol       Date:  2000-05

Review 3.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

4.  NMR assignment of Cdc42(T35A), an active Switch I mutant of Cdc42.

Authors:  Paul D Adams; Robert E Oswald
Journal:  Biomol NMR Assign       Date:  2007-11-13       Impact factor: 0.746

5.  Definition of the switch surface in the solution structure of Cdc42Hs.

Authors:  J L Feltham; V Dötsch; S Raza; D Manor; R A Cerione; M J Sutcliffe; G Wagner; R E Oswald
Journal:  Biochemistry       Date:  1997-07-22       Impact factor: 3.162

6.  Structure of the complex of Cdc42Hs with a peptide derived from P-21 activated kinase.

Authors:  D Gizachew; W Guo; K K Chohan; M J Sutcliffe; R E Oswald
Journal:  Biochemistry       Date:  2000-04-11       Impact factor: 3.162

7.  Concerted motion of a protein-peptide complex: backbone dynamics studies of an (15)N-labeled peptide derived from P(21)-activated kinase bound to Cdc42Hs.GMPPCP.

Authors:  D Gizachew; R E Oswald
Journal:  Biochemistry       Date:  2001-12-04       Impact factor: 3.162

8.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

Review 9.  Ras signaling pathway proteins as therapeutic targets.

Authors:  A A Adjei
Journal:  Curr Pharm Des       Date:  2001-11       Impact factor: 3.116

10.  Dominant inhibitory mutations in the Mg(2+)-binding site of RasH prevent its activation by GTP.

Authors:  C L Farnsworth; L A Feig
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

View more
  1 in total

1.  Active and Inactive Cdc42 Differ in Their Insert Region Conformational Dynamics.

Authors:  Nurit Haspel; Hyunbum Jang; Ruth Nussinov
Journal:  Biophys J       Date:  2020-12-19       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.